Immunocellular Therapeutics Ltd. (OTCBB: IMUC) is a biopharmaceutical company focused on improving cancer treatments through new immune-based products. Unlike similar companies, such as ImmunoGen Inc. (NASDAQ: IMGN) and Dendreon Corp. (NASDAQ: DNDN), IMUC is developing immunotherapies that target cancer stem cells in addition to normal cancer cells as a means to delay and prevent cancer
ALR Technologies Inc. (OTCBB: ALRT), developer of the revolutionary Health-e-Connect system, operating in the telehealth industry alongside companies like American Medical Alert (NASDAQ: AMAC) and Verizon (NYSE: VZ), could dramatically change the way diabetes is treated by effectively monitoring people with diabetes at home. And given the growing instances of diabetes in our society, this
Cardium Therapeutics (Amex: CXM), a developer and acquirer of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, similar to companies like Impax Laboratories Inc. (Nasdaq: IPXL) and Lannette Company Inc. (AMEX: LCI), today announced FDA 510(k) Clearance for U.S. Marketing
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, today announced the pricing of its initial public offering of 5,500,000 shares of
Since the late 1990’s, the world has been told that using our own stem cells would someday lead to cures and treatments for unmet medical needs. ALS, Alzheimer’s, Parkinson’s, macular degeneration (AMD) and acute myocardial
Immunocellular Therapeutics Ltd. (OTCBB: IMUC) is a biopharmaceutical company focused on improving cancer treatments through new immune-based products. Unlike other cancer treatment companies, such as Dendreon (NASDAQ: DNDN), Oncothyreon (NASDAQ: ONTY) , IMUC is developing
Amarantus BioSciences Inc. (OTCBB: AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic protein that could change the way many major diseases are treated. Unlike Insmed Inc. (NASDAQ:INSM) or Alexion Pharmaceuticals Inc. (NASDAQ:
Immunocellular Therapeutics Ltd. (OTCBB: IMUC) is a biopharmaceutical company focused on improving cancer treatments through new immune-based products. Unlike similar companies, such as ImmunoGen Inc. (NASDAQ: IMGN) and Dendreon Corp. (NASDAQ: DNDN), IMUC is developing
Amarantus BioSciences Inc. (OTCBB: AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic protein that could change the way many major diseases are treated. Unlike Insmed Inc. (NASDAQ:INSM) or Alexion Pharmaceuticals Inc. (NASDAQ:
ALR Technologies Inc. (OTCBB: ALRT), an innovative medical device company, offers a unique software solution aimed at improving patient adherence to care plans in the diabetes industry working alongside companies like Abbott Laboratories (NYSE: ABT)
Amarantus BioSciences Inc. (OTCBB: AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic protein that could change the way many major diseases are treated. Unlike Insmed Inc. (NASDAQ:INSM) or Alexion Pharmaceuticals Inc. (NASDAQ:
Cardium Therapeutics (Amex: CXM), a developer and acquirer of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, similar to companies
Amarantus BioSciences Inc. (OTCBB: AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic protein that could change the way many major diseases are treated. Unlike Insmed Inc. (NASDAQ:INSM) or Alexion Pharmaceuticals Inc. (NASDAQ:
Cardium Therapeutics (NYSE Amex: CXM), a developer and acquirer of innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs and definable pathways to commercialization, like companies such as Nutraceutical
MabCure Inc. (PINK SHEETS: MBCI) is a biotechnology company focused on changing the perception that cancer is an incurable disease. Unlike Dendreon Corporation (NASDAQ: DNDN) or Generex Biotechnology Corporation (PINK SHEETS: GNBT), the company is
© 2011 Accelerize New Media. All rights reserved.